Drug · DIN 02493233
BALVERSA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 9, 2019; first marketed December 9, 2019.
- Drug Identification Number (DIN)
- 02493233
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Erdafitinib L01EN01
- Class
- Human
- Record last updated
- February 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ERDAFITINIB | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 25, 2019: NOC 22821New Drug Submission (NDS)
Other DINs named BALVERSA
- DIN 02493217 · Marketed
- DIN 02493225 · Marketed
- DIN 02493241 · Approved